Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Prostatectomy Celecoxib in Prostate Cancer
NCT02840162Phase 2Terminated
- Sponsor
- OHSU Knight Cancer Institute
- Start
- May 2001
- Primary completion
- Jan 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in prostate cancer (PCa) comparing Celecoxib with Placebo (2 arms). Primary endpoint: Apoptosis Index at 4 weeks. Started May 2001; status: terminated.
02
Drugs
celecoxib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02840162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02840162.